TIFFANY EPPS: Open Payments
NPI 1881210458 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 5 payments from 5 companies in 2025. Trend: 2023 $207 · 2024 $873 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $166 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Alnylam Pharmaceuticals Inc. | 1 | $111 |
| Gilead Sciences, Inc. | 1 | $110 |
| Cipher Pharmaceuticals US LLC | 1 | $55 |
Products named: SYMPLICITY G3, ONPATTRO, Yeztugo, Natroba.
Industry payments across PA — which companies pay providers there.
